Menu

Experience

Asher Herzog

    • Centessa Pharmaceuticals – $380 Million IPO 


    • Kadmon Holdings – $240 Million Convertible Notes Offering 


    • Billtrust to Combine With South Mountain, a Special Purpose Acquisition Company, at $1.3 Billion Value 


    • Orphazyme – $84 Million IPO 


    • Dyne Therapeutics – $268 Million IPO 


    • PolyPid – $69 Million IPO 


    • Legend Biotech - $487 Million IPO 


    • Reata Pharmaceuticals – $505 Million Follow-On Offering